RetinaLyze International

RetinaLyze International Safe, fast and efficient retinal investigations with RetinaLyze AI and Telemedicine. Retinalyze is based on the vision to prevent loss of eyesight.

Worldwide diabetes is an increasing problem and +300 million registered diabetics (type 1 or 2) are expected in 2020. Furthermore by 2020 +250 million unregistered diabetics are expected. One of the most feared consequences of diabetes is retinal diabetic pathology since this can lead to blindness. Early diagnosis is crucial – and possible with Retinalyze. A good diabetic plan and a non-complicated laser treatment can prevent loss of sight and blindness. Our mission is to make it easier for people all over the world to have their eyes tested and prevent the tragic consequences caused by late treatment of retinal lesions. Retinalyze System A/S is a registered company in Denmark.

is around the corner – see you in Milan 🇮🇹From January 31 – February 2, 2026, the global optometry and ophthalmology c...
28/01/2026

is around the corner – see you in Milan 🇮🇹

From January 31 – February 2, 2026, the global optometry and ophthalmology community gathers at MIDO – and RetinaLyze will be there!

👉 You can experience RetinaLyze at two locations in Pavilion 3:
FE-Group srl / Frastema Ophthalmics / Easyopht Group: Booths C14, C20 & D13
Topcon Healthcare / Topcon Healthcare Europe: Booths M22 & N21

If you are curious about how AI-supported retinal screening can fit naturally into daily clinical or optical workflows, this is a great opportunity to see it in practice, ask questions, and exchange perspectives.

MIDO is all about innovation, collaboration, and real-world solutions – and we are looking forward to many good conversations with optometrists, ophthalmologists, and industry partners.

See you in Milan!

Celebrating a powerful collaboration: RetinaLyze x MedibrixAt RetinaLyze, we believe that eye care workflows should be a...
26/01/2026

Celebrating a powerful collaboration: RetinaLyze x Medibrix

At RetinaLyze, we believe that eye care workflows should be as seamless as the care professionals provide every day. That’s why we’re excited to highlight our cooperation with Medibrix!

A modular, web-based platform built to shape new clinical workflows through customizable, interoperable “bricks.”

Together, we’re helping clinics, optical chains, and healthcare organizations create smarter, more connected patient journeys.

Medibrix offers a full suite of bricks tailored for optometry and ophthalmology teams, including:
• Enterprise booking and smooth scheduling flows
• Pre- and post-visit questionnaires that reduce chair time
• Customer plans & targeted outreach to strengthen follow-up and retention
• Assisted and remote refraction for flexible service delivery
• Clinical decision support (CDSS) with integrated AI including RetinaLyze’s instant retinal analysis
• Optical Resource Centers that unify data, devices, and processes

By integrating RetinaLyze® AI screening into the Medibrix ecosystem, we’re helping eye care professionals deliver faster, more standardized and preventive care. Whether they’re in a single practice, a large chain, or part of a broader healthcare network.

A big thank you to the teams at Medibrix, and our partners across optometry and ophthalmology who continue to push innovation forward.

Here’s to building the future of eye care, one brick at a time. 👁️✨

The redesigned clinical PDF report is now available to all customers. This revamped report is built to improve clarity a...
21/01/2026

The redesigned clinical PDF report is now available to all customers.

This revamped report is built to improve clarity and communication at every step of the eye care workflow.

With a cleaner, more modern layout and integrated visual elements, including high-quality retinal images, OCT scans, and AI overlays, clinicians can now share findings with colleagues and patients more intuitively than ever before.

Whether you’re making a referral, explaining results to a patient, or collaborating across care teams, this report brings key insights forward at a glance.

Clear definitions of triage outcomes and a patient-friendly glossary enhance understanding and support informed decision-making. We’ve aligned the format across modalities, from diabetic retinopathy to glaucoma as well as fundus to OCT, bringing consistency and confidence to clinical documentation.

A step forward in how we communicate eye health! Thanks to all our partners and users who continue to shape better care together.

19/01/2026

Thank you, opti 2026.

What a great few days. Inspiring conversations, honest questions, and a strong shared focus on the future of eye care.

At RetinaLyze International, we truly appreciate everyone who stopped by our RetinaLyze DACH booth to talk about AI in eye screening, real-world workflows, and how technology can support, not replace, professional expertise.

Once again, showed that trust, empathy, and human judgment remain at the core of healthcare. AI is powerful, but its real value comes when it’s combined with skilled optometrists, opticians, and ophthalmologists who know their patients.

A big thank you to the entire team and everyone who helped make it special!

You might have met Barbara Anthonsen Wohlgemuth, Michael Anthonsen, Kevin Körbs and Patrick Körbs as well as the teams from OCULUS Optikgeräte GmbH - International, Topcon Deutschland Medical, Mediconsult AG, Rupp + Hubrach Optik GmbH, Breitfeld & Schliekert GmbH and OPTIC-HANDEL FRAGSTEIN.

We’re leaving Munich inspired, motivated, and already looking ahead.

See you at the next one!

So fun to catch up with happy customers at opti 2026!Thank you for visiting Mr. Martin Birk! 😄 Visit us on the last day ...
17/01/2026

So fun to catch up with happy customers at opti 2026!

Thank you for visiting Mr. Martin Birk! 😄

Visit us on the last day of OPTI at the RetinaLyze DACH/Likomed/TOMEY GmbH booth C4 263.

You can also experience our new 3D Glaucoma feature at the booths of:
OCULUS Optikgeräte GmbH - International
Topcon Deutschland Medical,
Mediconsult AG,
Rupp + Hubrach Optik GmbH,
Breitfeld & Schliekert GmbH or
OPTIC-HANDEL FRAGSTEIN

See you! 😁

16/01/2026

Wow! Thank you for the overwhelming interest in our new 3D glaucoma feature at !

Your feedback - just one day into opti – makes us so happy.

Visit us on Saturday or Sunday at the RetinaLyze DACH/Likomed/TOMEY GmbH booth C4 263 or at the booths of:

OCULUS Optikgeräte GmbH - International
Topcon Deutschland Medical,
Mediconsult AG,
Rupp + Hubrach Optik GmbH,
Breitfeld & Schliekert GmbH or
OPTIC-HANDEL FRAGSTEIN
and experience it yourself!

See you there!

Come visit RetinaLyze DACH at stand C4 / 263! We’re presenting:- a new, clearer PDF report that makes communication wit...
16/01/2026

Come visit RetinaLyze DACH at stand C4 / 263!

We’re presenting:
- a new, clearer PDF report that makes communication with patients and ophthalmologists easier
- a brand-new glaucoma feature: 3D insights into the optic nerve head from standard fundus images
- an AI workflow that keeps the optometrist as the first point of contact, supported by a backup ophthalmologist network

👓 Meet Kevin & Patrick Körbs, opticians using RetinaLyze every day, sharing real-world experience from their practice.

🤝 On site with the RetinaLyze DACH team, Michael and Barbara, and our partners, including LikoMed GmbH.

16/01/2026

Come visit RetinaLyze DACH at stand C4 / 263!

We’re presenting:
- a new, clearer PDF report that makes communication with patients and ophthalmologists easier
- a brand-new glaucoma feature: 3D insights into the optic nerve head from standard fundus images
- an AI workflow that keeps the optometrist as the first point of contact, supported by a backup ophthalmologist network

👓 Meet Kevin & Patrick Körbs, opticians using RetinaLyze every day, sharing real-world experience from their practice.

🤝 On site with the RetinaLyze DACH team, Michael and Barbara, and our partners, including LikoMed GmbH.

15/01/2026

Michael Anthonsen and Barbara Anthonsen Wohlgemuth from RetinaLyze DACH look forward to welcoming you at Hall C4 Stand 263 at opti tomorrow!

AI in eye screening should strengthen optometrists - not replace them.That’s exactly what RetinaLyze is showing at opti ...
14/01/2026

AI in eye screening should strengthen optometrists - not replace them.

That’s exactly what RetinaLyze is showing at opti 2026 in Munich.

At Stand C4 / 263, we’re presenting:
- a new, clearer PDF report that makes communication with patients and ophthalmologists easier
- a brand-new glaucoma feature: 3D insights into the optic nerve head from standard fundus images
- an AI workflow that keeps the optometrist as the first point of contact, supported by a backup ophthalmologist network

👓 Meet Kevin & Patrick Körbs, opticians using RetinaLyze every day, sharing real-world experience from their practice.

🤝 On site with the RetinaLyze DACH team, Michael Anthonsen and Barbara Anthonsen Wohlgemuth, and our partners, including LikoMed GmbH.

You’ll also find RetinaLyze at:
OCULUS Optikgeräte GmbH, Topcon Deutschland Medical, Mediconsult AG, Rupp + Hubrach Optik GmbH, Breitfeld & Schliekert GmbH, OPTIC-HANDEL FRAGSTEIN

If you’re curious how AI can support your expertise and workflow, come by and see it live!

📍 opti 2026 | Stand C4 / 263

12/01/2026

The RetinaLyze Glaucoma 3D overlay is launching at opti 2026 this week!

The best news is that the feature will be made available for all customers at no additional cost. 😁

Visit us at booth 263 in Hall C4 to witness the new RetinaLyze 3D glaucoma AI live.

Michael Anthonsen and Barbara Anthonsen Wohlgemuth from RetinaLyze DACH will be there to greet you.

See you at !

Make sure that patients understand what’s happening.At RetinaLyze, we see this issue every day in clinics using AI-suppo...
07/01/2026

Make sure that patients understand what’s happening.

At RetinaLyze, we see this issue every day in clinics using AI-supported screening.

The technology may be advanced, but the conversation with the patient has to stay simple, human, and reassuring.

What works in practice?
• Explain AI as decision support, not a decision maker
• Use everyday analogies – “a second pair of trained eyes”
• Be clear that the clinician remains fully responsible
• Show results visually and relate them to the specific patient
• Invite questions - curiosity builds trust

Patients don’t need to understand algorithms. They need to understand why the tool helps their care.

When clinicians communicate AI with confidence and transparency, something interesting happens:

AI strengthens the clinician-patient relationship without distancing the patient.

Adresse

Mileparken 10C
Skovlunde
2740

Åbningstider

Mandag 09:00 - 17:30
Tirsdag 09:00 - 17:30
Onsdag 09:00 - 17:30
Torsdag 09:00 - 17:30
Fredag 09:00 - 17:30

Internet side

Underretninger

Vær den første til at vide, og lad os sende dig en email, når RetinaLyze International sender nyheder og tilbud. Din e-mail-adresse vil ikke blive brugt til andre formål, og du kan til enhver tid afmelde dig.

Kontakt Praksis

Send en besked til RetinaLyze International:

Genveje

Del

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Prevention of blindness through AI

RetinaLyze prevents loss of eyesight by making eye screening accessible. 80% of all blindness is preventable. Early screening and diagnosis is crucial and possible with Retinalyze'​ automated retinal screening tools and telemedicine solutions. Our mission is to make it easier for people all over the world to have their eyes tested and prevent the tragic consequences caused by late treatment of retinal lesions.

RetinaLyze® is a screening software, which helps eye care professionals perform screenings for eye diseases in a safe and efficient manner. The automated algorithm (AI) module detects eye diseases by analyzing fundus images. It can be used as a clinical decision support system (CDSS) or as a screening tool in conjunction with the telemedicine module. Retinalyze System A/S is a registered company in Denmark. Check us out at https://RetinaLyze.com.